摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙氧基-1-丁醇 | 111-73-9

中文名称
4-乙氧基-1-丁醇
中文别名
——
英文名称
4-ethoxybutan-1-ol
英文别名
4-ethoxy-1-butanol;4-Aethoxy-1-butanol;butylene glycol ethyl ether
4-乙氧基-1-丁醇化学式
CAS
111-73-9
化学式
C6H14O2
mdl
MFCD00040194
分子量
118.176
InChiKey
QRUOTIJTSNETKW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    180-181 °C(Press: 756 Torr)
  • 密度:
    0.9019 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    8
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2909499000

SDS

SDS:94ea63288c64252b0330fe982702ebcc
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE AND PHARMACEUTICALS CONTAINING THE SAME
    申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
    公开号:US20160002251A1
    公开(公告)日:2016-01-07
    The present invention provides a dihydropyridazine-3,5-dione derivative or a salt thereof, or a solvate of the compound or the salt, a pharmaceutical drug, a pharmaceutical composition, a sodium-dependent phosphate transporter inhibitor, and a preventive and/or therapeutic agent for hyperphosphatemia, secondary hyperparathyroidism, chronic renal failure, chronic kidney disease, and arteriosclerosis associated with vascular calcification comprising the compound as an active ingredient, and a method for prevention and/or treatment.
    本发明提供了一种二氢吡啶嗪-3,5-二酮衍生物或其盐,或化合物或盐的溶剂化合物,一种药物,一种药物组合物,一种钠依赖性磷酸盐转运体抑制剂,以及作为活性成分的化合物的高磷血症、继发性甲状旁腺功能亢进症、慢性肾功能衰竭、慢性肾病和与血管钙化相关的动脉硬化的预防和/或治疗剂,以及预防和/或治疗的方法。
  • AROMATIC AMINE COMPOUND, CURING AGENT FOR EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING AROMATIC AMINE COMPOUND
    申请人:TOKYO OHKA KOGYO CO., LTD.
    公开号:US20210130284A1
    公开(公告)日:2021-05-06
    An aromatic amine compound capable of satisfactorily forming a cured product having exceptional alkali resistance by reaction with an epoxy compound; a curing agent for an epoxy compound, the curing agent including the aromatic amine compound; a curable composition including the curing agent for an epoxy compound; a cured product of the curable composition; a method for producing the cured product; and a method for producing the abovementioned aromatic amine compound. The aromatic amine compound has a structure such that a specific position in a central skeleton comprising a fused ring such as a fluorene ring is substituted with a side-chain group including two aromatic groups linked by a flexible bond such as an amide bond, at least one amino group is bonded to the end of the side-chain group, and the structure has no hydroxyl groups.
    一种芳香胺化合物,通过与环氧化合物反应能够满意地形成具有异常碱性抗性的固化产品;一种环氧化合物的固化剂,该固化剂包括芳香胺化合物;一种包括环氧化合物的固化剂的可固化组合物;可固化组合物的固化产品;生产所述固化产品的方法;以及生产上述芳香胺化合物的方法。该芳香胺化合物具有这样的结构,即中心骨架中的特定位置包括类似于芴环的融合环,该位置被取代为包括通过柔性键(如酰胺键)连接的两个芳香基的侧链基团,至少一个氨基固定在侧链基团的末端,并且该结构不含羟基。
  • ANTIREFLECTIVE COMPOSITIONS WITH THERMAL ACID GENERATORS
    申请人:Rohm and Haas Electronic Materials Korea Ltd.
    公开号:US20190085173A1
    公开(公告)日:2019-03-21
    New methods and substrates are provided that include antireflective compositions that comprise one or more thermal acid generators.
    提供了包括一个或多个热酸发生剂的防反射组分的新方法和基板。
  • MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS
    申请人:Precursor Energetics, Inc.
    公开号:US20150218190A1
    公开(公告)日:2015-08-06
    Molecular precursor compounds, processes and compositions for making Zn-Group 13 mixed oxide materials including IZO, GZO, AZO and BZO, by providing inks comprising a molecular precursor compound having the formula M A a Zn(OROR) 3a+2 , and printing or depositing the inks on a substrate. The printed or deposited ink films can be treated to convert the molecular precursor compounds to a material.
    分子前体化合物、制备Zn-Group 13混合氧化物材料(包括IZO、GZO、AZO和BZO)的过程和组合物,方法是提供包含具有公式M的分子前体化合物的油墨,在基底上印刷或沉积这些油墨。印刷或沉积的油墨膜可以经处理转化为材料。
  • Organic Compounds
    申请人:Maibaum Juergen Klaus
    公开号:US20090076062A1
    公开(公告)日:2009-03-19
    Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I) and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising these compounds and methods of administering them for the treatment of hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, unstable coronary syndrome, diastolic dysfunction, chronic kidney disease, hepatic fibrosis, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty, raised intra-ocular pressure, glaucoma, abnormal vascular growth, hyperaldosteronism, cognitive impairment, alzheimers, dementia, anxiety states and cognitive disorders.
    揭示了具有抑制肾素作用的δ-氨基-γ-羟基-ω-芳基-烷酸酰胺化合物的化学式(I)及其盐。还揭示了包括这些化合物的药物组合物以及用于治疗高血压、动脉粥样硬化、不稳定性冠状动脉综合征、充血性心力衰竭、心肌肥大、心脏纤维化、心肌梗死后心肌病、不稳定性冠状动脉综合征、舒张功能障碍、慢性肾病、肝纤维化、糖尿病并发症(如肾病、血管病和神经病变)、冠状血管疾病、血管成形术后再狭窄、眼内压升高、青光眼、异常血管生长、高醛固酮症、认知障碍、阿尔茨海默病、痴呆症、焦虑状态和认知障碍的治疗方法。
查看更多